Day: November 27, 2023

GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)

Staff November 27, 2023

Clinical development plan leveraging 505(b)(2) regulatory pathway Initiation of Phase 2a biomarker study on track to start before year end...

Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024

Staff November 27, 2023

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetesNew...

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

Staff November 27, 2023

GIMOTI now holds four listed patents with coverage through 2029SOLANA BEACH, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma,...

SteraMist Welcomes Sterile Grow as U.S. Distributor for Food Safety and Cannabis

Staff November 27, 2023

-Partnership Expands TOMI’s Market in Food, Agriculture, and Cannabis Industries -FREDERICK, Md., Nov. 27, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental...

Safety Shot, Inc Hires Securities Litigation Attorney Mark R. Basile, Esq. and The Basile Law Firm P.C. – Dilution Funding and Short and Distort Experts

Staff November 27, 2023

JUPITER, FLORIDA., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Safety Shot, Inc.(NASDAQ: SHOT) (“SHOT” or the “Company”), first patented beverage on...

Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution

Staff November 27, 2023

NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical...

INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease

Staff November 27, 2023

Boca Raton, Florida, Nov. 27, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company...

Day: November 27, 2023

GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)

Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

SteraMist Welcomes Sterile Grow as U.S. Distributor for Food Safety and Cannabis

Safety Shot, Inc Hires Securities Litigation Attorney Mark R. Basile, Esq. and The Basile Law Firm P.C. – Dilution Funding and Short and Distort Experts

Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists

Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010

Accolade To Present at Piper Sandler 35th Annual Healthcare Conference

Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent

DLH to Announce Fiscal 2023 Fourth Quarter Financial Results

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer

Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023

Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

Roivant and Priovant Announce Results from Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus

INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease

Nicole Garrett and Under Pressure Hyperbarics Lead the Charge in Wellness Education With Immersive Events at L.A. Fashion Weekend and Beyond

Beacon Healthcare Systems Expands Leadership Team with Addition of Ayman Mohamed as Chief Technology Officer

Talkiatry Ranked Number 6 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Bright Light Imaging Leverages Alpha Nodus’s Gravity Auth, Enhanced by Integration with ADS’s MedicsRIS, to Streamline Patient Care

Telerehabilitation Systems Market to Expand by USD 532.9 Million (2024-2028), Rising Chronic Disease Cases Driving Revenue, AI Impacting Market Trends – Technavio

You may have missed